147 related articles for article (PubMed ID: 15884943)
1. Design, synthesis, and biological evaluation of HSP90 inhibitors based on conformational analysis of radicicol and its analogues.
Moulin E; Zoete V; Barluenga S; Karplus M; Winssinger N
J Am Chem Soc; 2005 May; 127(19):6999-7004. PubMed ID: 15884943
[TBL] [Abstract][Full Text] [Related]
2. Concise synthesis of pochonin A, an HSP90 inhibitor.
Moulin E; Barluenga S; Winssinger N
Org Lett; 2005 Dec; 7(25):5637-9. PubMed ID: 16321010
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Hsp90 with synthetic macrolactones: synthesis and structural and biological evaluation of ring and conformational analogs of radicicol.
Proisy N; Sharp SY; Boxall K; Connelly S; Roe SM; Prodromou C; Slawin AM; Pearl LH; Workman P; Moody CJ
Chem Biol; 2006 Nov; 13(11):1203-15. PubMed ID: 17114002
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of the biosynthesis of radicicol, an Hsp90 inhibitor resorcylic acid lactone from Chaetomium chiversii.
Wang S; Xu Y; Maine EA; Wijeratne EM; Espinosa-Artiles P; Gunatilaka AA; Molnár I
Chem Biol; 2008 Dec; 15(12):1328-38. PubMed ID: 19101477
[TBL] [Abstract][Full Text] [Related]
5. Development of radicicol analogues.
Soga S; Shiotsu Y; Akinaga S; Sharma SV
Curr Cancer Drug Targets; 2003 Oct; 3(5):359-69. PubMed ID: 14529387
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and structure--activity relationships for chimeric inhibitors of Hsp90.
Shen G; Wang M; Welch TR; Blagg BS
J Org Chem; 2006 Sep; 71(20):7618-31. PubMed ID: 16995666
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
Roe SM; Prodromou C; O'Brien R; Ladbury JE; Piper PW; Pearl LH
J Med Chem; 1999 Jan; 42(2):260-6. PubMed ID: 9925731
[TBL] [Abstract][Full Text] [Related]
8. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.
Soga S; Neckers LM; Schulte TW; Shiotsu Y; Akasaka K; Narumi H; Agatsuma T; Ikuina Y; Murakata C; Tamaoki T; Akinaga S
Cancer Res; 1999 Jun; 59(12):2931-8. PubMed ID: 10383157
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric synthesis of pochonin E and F, revision of their proposed structure, and their conversion to potent Hsp90 inhibitors.
Karthikeyan G; Zambaldo C; Barluenga S; Zoete V; Karplus M; Winssinger N
Chemistry; 2012 Jul; 18(29):8978-86. PubMed ID: 22696415
[TBL] [Abstract][Full Text] [Related]
10. Chemistry and biology of resorcylic acid lactones.
Winssinger N; Barluenga S
Chem Commun (Camb); 2007 Jan; (1):22-36. PubMed ID: 17279252
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Hsp90 with resorcylic acid macrolactones: synthesis and binding studies.
Day JE; Sharp SY; Rowlands MG; Aherne W; Lewis W; Roe SM; Prodromou C; Pearl LH; Workman P; Moody CJ
Chemistry; 2010 Sep; 16(34):10366-72. PubMed ID: 20661961
[TBL] [Abstract][Full Text] [Related]
12. Understanding the Hsp90
Magwenyane AM; Mhlongo NN; Lawal MM; Amoako DG; Somboro AM; Sosibo SC; Shunmugam L; Khan RB; Kumalo HM
Molecules; 2020 Apr; 25(8):. PubMed ID: 32295059
[TBL] [Abstract][Full Text] [Related]
13. Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
Turbyville TJ; Wijeratne EM; Liu MX; Burns AM; Seliga CJ; Luevano LA; David CL; Faeth SH; Whitesell L; Gunatilaka AA
J Nat Prod; 2006 Feb; 69(2):178-84. PubMed ID: 16499313
[TBL] [Abstract][Full Text] [Related]
14. New efficient synthesis of resorcinylic macrolides via ynolides: establishment of cycloproparadicicol as synthetically feasible preclinical anticancer agent based on Hsp90 as the target.
Yang ZQ; Geng X; Solit D; Pratilas CA; Rosen N; Danishefsky SJ
J Am Chem Soc; 2004 Jun; 126(25):7881-9. PubMed ID: 15212536
[TBL] [Abstract][Full Text] [Related]
15. The Hsp90 inhibitor radicicol interacts with the ATP-binding pocket of bacterial sensor kinase PhoQ.
Guarnieri MT; Zhang L; Shen J; Zhao R
J Mol Biol; 2008 May; 379(1):82-93. PubMed ID: 18440021
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of archaeal growth and DNA topoisomerase VI activities by the Hsp90 inhibitor radicicol.
Gadelle D; Bocs C; Graille M; Forterre P
Nucleic Acids Res; 2005; 33(7):2310-7. PubMed ID: 15849317
[TBL] [Abstract][Full Text] [Related]
17. Hsp90 inhibition with resorcyclic acid lactones (RALs).
Winssinger N; Fontaine JG; Barluenga S
Curr Top Med Chem; 2009; 9(15):1419-35. PubMed ID: 19860733
[TBL] [Abstract][Full Text] [Related]
18. Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones.
Schulte TW; Akinaga S; Murakata T; Agatsuma T; Sugimoto S; Nakano H; Lee YS; Simen BB; Argon Y; Felts S; Toft DO; Neckers LM; Sharma SV
Mol Endocrinol; 1999 Sep; 13(9):1435-48. PubMed ID: 10478836
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Hsp90 chaperone: synthesis of novel resorcylic acid macrolactone inhibitors of Hsp90.
Day JE; Sharp SY; Rowlands MG; Aherne W; Workman P; Moody CJ
Chemistry; 2010 Mar; 16(9):2758-63. PubMed ID: 20087915
[TBL] [Abstract][Full Text] [Related]
20. Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol.
Sharma SV; Agatsuma T; Nakano H
Oncogene; 1998 May; 16(20):2639-45. PubMed ID: 9632140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
